Rapt Therapeutics Stock Price History
| RAPT Stock | USD 1.15 0.06 5.50% |
Below is the normalized historical share price chart for RAPT Therapeutics extending back to October 31, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of RAPT Therapeutics stands at 1.15, as last reported on the 20th of March, with the highest price reaching 1.16 and the lowest price hitting 1.10 during the day.
If you're considering investing in RAPT Stock, it is important to understand the factors that can impact its price. RAPT Therapeutics is abnormally volatile given 3 months investment horizon. RAPT Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0837, which implies the company had a 0.0837 % return per unit of standard deviation over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.26% are justified by taking the suggested risk. Use RAPT Therapeutics Market Risk Adjusted Performance of 0.1925, coefficient of variation of 2222.45, and Mean Deviation of 5.29 to evaluate company specific risk that cannot be diversified away.
At this time, RAPT Therapeutics' Common Stock is comparatively stable compared to the past year. Capital Stock is likely to gain to about 13.7 K in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 29.8 M in 2025. . Price To Sales Ratio is likely to drop to 208.09 in 2025. Price Earnings Ratio is likely to drop to -0.52 in 2025. RAPT Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 31st of October 2019 | 200 Day MA 1.995 | 50 Day MA 1.2012 | Beta (0.31) |
RAPT |
Sharpe Ratio = 0.0837
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RAPT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 15.03 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.26 actual daily | 25 75% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average RAPT Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RAPT Therapeutics by adding it to a well-diversified portfolio.
Price Book 0.7785 | Enterprise Value Ebitda (10.73) | Price Sales 411.2189 | Shares Float 58.5 M | Wall Street Target Price 5 |
RAPT Therapeutics Stock Price History Chart
There are several ways to analyze RAPT Stock price data. The simplest method is using a basic RAPT candlestick price chart, which shows RAPT Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 26, 2024 | 1.81 |
| Lowest Price | December 19, 2024 | 0.81 |
RAPT Therapeutics March 20, 2025 Stock Price Synopsis
Various analyses of RAPT Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell RAPT Stock. It can be used to describe the percentage change in the price of RAPT Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of RAPT Stock.| RAPT Therapeutics Accumulation Distribution | 73,038 | |
| RAPT Therapeutics Price Action Indicator | 0.05 | |
| RAPT Therapeutics Price Daily Balance Of Power | 1.00 | |
| RAPT Therapeutics Price Rate Of Daily Change | 1.06 |
RAPT Therapeutics March 20, 2025 Stock Price Analysis
RAPT Stock Price History Data
The price series of RAPT Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 1.0 with a coefficient of variation of 18.74. The price distribution for the period has arithmetic mean of 1.21. The median price for the last 90 days is 1.17. The company completed stock split (21:1) on December 14, 2010.| Open | High | Low | Close | Volume | ||
| 03/19/2025 | 1.12 | 1.16 | 1.10 | 1.15 | 1,412,066 | |
| 03/18/2025 | 1.12 | 1.14 | 1.08 | 1.09 | 612,789 | |
| 03/17/2025 | 1.14 | 1.16 | 1.09 | 1.12 | 424,386 | |
| 03/14/2025 | 1.20 | 1.22 | 1.14 | 1.14 | 376,931 | |
| 03/13/2025 | 1.25 | 1.26 | 1.16 | 1.17 | 429,537 | |
| 03/12/2025 | 1.14 | 1.30 | 1.13 | 1.25 | 579,044 | |
| 03/11/2025 | 1.08 | 1.18 | 1.04 | 1.14 | 669,642 | |
| 03/10/2025 | 1.13 | 1.17 | 1.06 | 1.07 | 713,297 | |
| 03/07/2025 | 1.13 | 1.19 | 1.12 | 1.13 | 382,838 | |
| 03/06/2025 | 1.09 | 1.20 | 1.09 | 1.12 | 337,379 | |
| 03/05/2025 | 1.10 | 1.15 | 1.09 | 1.13 | 412,002 | |
| 03/04/2025 | 1.05 | 1.14 | 1.02 | 1.10 | 681,968 | |
| 03/03/2025 | 1.11 | 1.14 | 1.05 | 1.05 | 339,628 | |
| 02/28/2025 | 1.07 | 1.14 | 1.07 | 1.14 | 325,280 | |
| 02/27/2025 | 1.19 | 1.20 | 1.07 | 1.09 | 714,067 | |
| 02/26/2025 | 1.15 | 1.19 | 1.10 | 1.17 | 490,370 | |
| 02/25/2025 | 1.20 | 1.22 | 1.13 | 1.15 | 433,204 | |
| 02/24/2025 | 1.25 | 1.28 | 1.18 | 1.18 | 375,800 | |
| 02/21/2025 | 1.29 | 1.32 | 1.21 | 1.25 | 295,658 | |
| 02/20/2025 | 1.20 | 1.29 | 1.20 | 1.26 | 470,662 | |
| 02/19/2025 | 1.18 | 1.25 | 1.18 | 1.20 | 409,240 | |
| 02/18/2025 | 1.21 | 1.30 | 1.18 | 1.20 | 332,568 | |
| 02/14/2025 | 1.22 | 1.25 | 1.19 | 1.20 | 264,640 | |
| 02/13/2025 | 1.16 | 1.21 | 1.15 | 1.19 | 282,567 | |
| 02/12/2025 | 1.15 | 1.19 | 1.12 | 1.16 | 263,917 | |
| 02/11/2025 | 1.13 | 1.18 | 1.10 | 1.17 | 553,800 | |
| 02/10/2025 | 1.15 | 1.16 | 1.10 | 1.15 | 486,160 | |
| 02/07/2025 | 1.18 | 1.25 | 1.13 | 1.16 | 395,729 | |
| 02/06/2025 | 1.19 | 1.22 | 1.13 | 1.18 | 362,722 | |
| 02/05/2025 | 1.13 | 1.21 | 1.12 | 1.21 | 487,050 | |
| 02/04/2025 | 1.15 | 1.16 | 1.07 | 1.11 | 764,300 | |
| 02/03/2025 | 1.12 | 1.20 | 1.10 | 1.14 | 721,300 | |
| 01/31/2025 | 1.17 | 1.17 | 1.12 | 1.14 | 420,900 | |
| 01/30/2025 | 1.21 | 1.22 | 1.11 | 1.14 | 682,800 | |
| 01/29/2025 | 1.18 | 1.20 | 1.14 | 1.17 | 2,696,000 | |
| 01/28/2025 | 1.17 | 1.19 | 1.12 | 1.18 | 640,900 | |
| 01/27/2025 | 1.15 | 1.23 | 1.14 | 1.16 | 954,300 | |
| 01/24/2025 | 1.19 | 1.25 | 1.15 | 1.18 | 971,900 | |
| 01/23/2025 | 1.22 | 1.24 | 1.15 | 1.19 | 1,491,389 | |
| 01/22/2025 | 1.20 | 1.28 | 1.17 | 1.22 | 719,980 | |
| 01/21/2025 | 1.24 | 1.27 | 1.18 | 1.20 | 862,935 | |
| 01/17/2025 | 1.20 | 1.26 | 1.13 | 1.20 | 885,452 | |
| 01/16/2025 | 1.18 | 1.22 | 1.13 | 1.19 | 1,036,237 | |
| 01/15/2025 | 1.13 | 1.29 | 1.13 | 1.20 | 1,564,599 | |
| 01/14/2025 | 1.22 | 1.25 | 1.07 | 1.10 | 1,312,552 | |
| 01/13/2025 | 1.30 | 1.31 | 1.16 | 1.21 | 2,473,213 | |
| 01/10/2025 | 1.40 | 1.44 | 1.27 | 1.32 | 2,379,488 | |
| 01/08/2025 | 1.57 | 1.60 | 1.41 | 1.45 | 882,737 | |
| 01/07/2025 | 1.67 | 1.72 | 1.54 | 1.60 | 1,200,541 | |
| 01/06/2025 | 1.67 | 1.73 | 1.60 | 1.72 | 1,180,758 | |
| 01/03/2025 | 1.60 | 1.78 | 1.60 | 1.67 | 1,127,951 | |
| 01/02/2025 | 1.59 | 1.79 | 1.55 | 1.63 | 1,972,257 | |
| 12/31/2024 | 1.65 | 1.73 | 1.56 | 1.58 | 2,749,511 | |
| 12/30/2024 | 1.71 | 1.76 | 1.55 | 1.62 | 2,104,197 | |
| 12/27/2024 | 1.82 | 1.94 | 1.69 | 1.69 | 3,475,554 | |
| 12/26/2024 | 1.95 | 2.09 | 1.72 | 1.81 | 9,777,978 | |
| 12/24/2024 | 1.59 | 1.81 | 1.55 | 1.73 | 5,293,991 | |
| 12/23/2024 | 1.52 | 2.32 | 1.46 | 1.74 | 141,065,406 | |
| 12/20/2024 | 0.80 | 0.88 | 0.80 | 0.83 | 707,377 | |
| 12/19/2024 | 0.82 | 0.85 | 0.79 | 0.81 | 464,302 | |
| 12/18/2024 | 0.85 | 0.93 | 0.81 | 0.82 | 580,023 |
About RAPT Therapeutics Stock history
RAPT Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for RAPT is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in RAPT Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing RAPT Therapeutics stock prices may prove useful in developing a viable investing in RAPT Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 40.8 M | 29.8 M | |
| Net Loss | -75.5 M | -79.2 M |
RAPT Therapeutics Quarterly Net Working Capital |
|
RAPT Therapeutics Stock Technical Analysis
RAPT Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
RAPT Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for RAPT Therapeutics' price direction in advance. Along with the technical and fundamental analysis of RAPT Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of RAPT to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.049 | |||
| Jensen Alpha | 0.972 | |||
| Total Risk Alpha | 2.21 | |||
| Sortino Ratio | 0.1455 | |||
| Treynor Ratio | 0.1825 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for RAPT Stock Analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.